Latest Blogs

Nov 24, 2021
Transitions are hard in a medical career, especially as the holidays approach, but you can offer colleagues the gift of a listening ear and a safe space. 
Nov 16, 2021
In an original poem, Dr. Alankrita Taneja evokes a lesson learned from her patients on "the hard spiritual truth about living each day and each moment as it comes while surrendering control of the outcome."  
Nov 02, 2021
We should start to implement and teach telemedicine earlier in training, so that new trainees can have all the tools needed to navigate and use this modality without any fear or limitation, said Dr. Tarek Haykal.
Oct 19, 2021
Dr. Samer Al Hadidi shares a personal story about the struggles he encountered during his first year of fellowship as he coped with the loss of his father.
Subscribe to this column

ASCO Commentary

ASCO Commentary provides an interactive platform for ASCO’s organizational leadership and senior staff to connect directly to ASCO’s membership and the wider oncology community.

Nov 03, 2021
ASCO president Dr. Everett E. Vokes and Nominating Committee chair Dr. Sharon H. Giordano have a call to action for all voting-eligible members.
Feb 21, 2018
Dr. Richard L. Schilsky describes ASCO's Targeted Agent and Profiling Utilization Registry (TAPUR) Study and similar independent studies worldwide.
Oct 28, 2016
Dr. Richard L. Schilsky outlines the Society's Target Agent and Profiling Utilization Registry (TAPUR) Study and similar international protocols. A global data sharing platform could greatly accelerate our ability to learn about new uses for currently approved targeted anticancer drugs.
Nov 02, 2015
Chief Medical Officer Dr. Richard L. Schilsky answers your questions about this exciting new opportunity in health care policy and advocacy.
Oct 26, 2015
Personalized cancer care is not a new concept, but its application has been enabled and enhanced by a far greater understanding of the biological underpinnings of cancer than ever existed before.
Nov 12, 2014
By Richard L. Schilsky, MD, FASCO, Chief Medical Officer of ASCO. During the past six weeks I’ve had the opportunity to attend cancer meetings in four countries on three continents. In September, I represented ASCO at the annual meeting of the Chinese Society of Clinical Oncology (CSCO) in Xiamen,...

Pages